Only the market cap matters. At $24m that wouldn't buy a house in Point Piper!
I think we're severely undervalued but most emerging biotec stocks have been sold off. I can't see sentiment changing anytime soon without some positive announcements. The board is top class, our adjutants work in the lab, we are doing experiments for one or more big pharma companies and we have $7m cash. I'm not selling at 1c.
Ann: Appendix 4C - Quarterly - 31 March 2023, page-101
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.40M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 154511 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 4813825 | 5 |
View Market Depth
| Last trade - 16.12pm 31/07/2024 (20 minute delay) ? |
| PAB (ASX) Chart |
Day chart unavailable